Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 17/20 | 0.61 |
| ▸ | PGR | P06401 | 15/20 | 0.61 |
| ▸ | NR3C2 | P08235 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4942036 | 0.90 | PGR (0.67) | NR3C1PGRNR3C2ALDH1A1 | |
| SCHEMBL4944636 | 0.88 | NR3C1 (0.75) | NR3C1PGRNR3C2ALDH1A1IMPDH2 | |
| SCHEMBL4936651 | 0.86 | NR3C1 (0.71) | NR3C1PGRNR3C2 | |
| SCHEMBL4936659 | 0.85 | NR3C1 (0.70) | NR3C1PGRNR3C2 | |
| SCHEMBL4433655 | 0.85 | NR3C1 (0.68) | NR3C1PGRNR3C2IMPDH2 | |
| SCHEMBL4945232 | 0.84 | NR3C1 (0.67) | NR3C1PGRNR3C2IMPDH2MAPT | |
| SCHEMBL4941804 | 0.84 | NR3C1 (0.62) | NR3C1PGRNR3C2IMPDH2MAPT | |
| SCHEMBL4944510 | 0.83 | NR3C1 (0.67) | NR3C1PGRNR3C2MAPT | |
| SCHEMBL4943669 | 0.83 | NR3C1 (0.65) | NR3C1PGRNR3C2 | |
| SCHEMBL7961842 | 0.83 | NR3C1 (0.79) | NR3C1PGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080171873-A1 | Synthesis of selected stereoisomers of certain substituted alcohols | BAUSCH & LOMB INCORPORATED | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171873-A1 | Synthesis of selected stereoisomers of certain substituted alcohols | ADH1A, ADH1C, ADH5 | NR3C1 74/4885PGR 3574/4885NR3C2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.